“Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study,” by Jorge Cortes, Eric Feldman, Karen Yee, David Rizzieri, Anjali S. Advani, Anthony Charman, Richard Spruyt, Martin Toal, and Hagop Kantarjian (Vol. 14, No. 4, April 2013, p. 354-362).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970037-8/abstract
Note: Lancet requires free registration prior to providing content. “Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study,” by Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, Karen Seiter, Gary Schiller, Elias Jabbour, Judy Chiao, and William Plunkett (Vol. 13, No. 11, November 2012, p. 1096-1104).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2812%2970436-9/abstract
Powered by WordPress
